Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia.
Saved in:
| Title: | Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia. |
|---|---|
| Authors: | Ravindra N; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Lack J; Integrated Data Sciences Section, National Institutes of Health, Bethesda, MD., Dalgard CL; The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD., vanCollenburg E; Bio-Rad Laboratories, Digital Biology Group, 5731, W. Las Positias Blvd, Pleasanton, CA., Corner A; Bio-Rad Laboratories, Digital Biology Group, 5731, W. Las Positias Blvd, Pleasanton, CA., Beppu L; Translational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Erba H; Duke University School of Medicine, Durham, NC., Othus M; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA., Radich JP; Translational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA., Dillon LW; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC., Hourigan CS; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC. |
| Source: | MedRxiv : the preprint server for health sciences [medRxiv] 2026 Jan 26. Date of Electronic Publication: 2026 Jan 26. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
